Skip to main content

Advertisement

Log in

Algorithms to Identify Nonmedical Opioid Use

  • Acute Pain Medicine (R Urman, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The rise in nonmedical opioid overdoses over the last two decades necessitates improved detection technologies. Manual opioid screening exams can exhibit excellent sensitivity for identifying the risk of opioid misuse but can be time-consuming. Algorithms can help doctors identify at-risk people. In the past, electronic health record (EHR)–based neural networks outperformed Drug Abuse Manual Screenings in sparse studies; however, recent data shows that it may perform as well or less than manual screenings. Herein, a discussion of several different manual screenings and recommendations is contained, along with suggestions for practice. A multi-algorithm approach using EHR yielded strong predictive values of opioid use disorder (OUD) over a large sample size. A POR (Proove Opiate Risk) algorithm provided a high sensitivity for categorizing the risk of opioid abuse within a small sample size. All established screening methods and algorithms reflected high sensitivity and positive predictive values. Neural networks based on EHR also showed significant effectiveness when corroborated with Drug Abuse Manual Screenings. This review highlights the potential of algorithms for reducing provider costs and improving the quality of care by identifying nonmedical opioid use (NMOU) and OUD. These tools can be combined with traditional clinical interviewing, and neural networks can be further refined while expanding EHR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

  1. Canan C, Polinski JM, Alexander GC, Kowal MK, Brennan TA, Shrank WH. Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review. J Am Med Inform Assoc. 2017;24(6):1204–10.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cochran G, Woo B, Lo-Ciganic W-H, Gordon AJ, Donohue JM, Gellad WF. Defining nonmedical use of prescription opioids within health care claims: a systematic review. Substance Abuse. 2015;36(2):192–202.

    Article  PubMed  Google Scholar 

  3. Overdose death rates. National Institutes of Health. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates. Published July 21, 2022. Accessed 11 Dec 2022.

  4. U.S. overdose deaths in 2021 increased half as much as in 2020 - but are still up 15%. Centers for Disease Control and Prevention. www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm. Published May 11, 2022. Accessed 11 Dec 2022.

  5. Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, et al. Predicting aberrant drug behavior in patients treated for chronic pain: the importance of abuse history. J Pain Symptom Manage. 2004;28(3):250–8.

    Article  PubMed  Google Scholar 

  6. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009;15(12):897–906.

    PubMed  Google Scholar 

  7. Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130(1):144–56.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and ‘problematic’ substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998;16(6):355–63.

    Article  CAS  PubMed  Google Scholar 

  9. Compton PA, Wu SM, Schieffer B, Pham Q, Naliboff BD. Introduction of a Self-report version of the prescription drug use questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage. 2008;36(4):383–95.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain. 1997;13(2):150–5.

    Article  CAS  PubMed  Google Scholar 

  11. Wickersham JA, Azar MM, Cannon CM, Altice FL, Springer SA. Validation of a brief measure of opioid dependence: the Rapid Opioid Dependence Screen (RODS) [published correction appears in J Correct Health Care. 2020;26(2):194]. J Correct Health Care. 2015;21(1):12–26. https://doi.org/10.1177/1078345814557513.

  12. Nielsen S, Picco L, Campbell G, et al. Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings. Pain Med. 2020;21(2):e79–88. https://doi.org/10.1093/pm/pnz213.

    Article  PubMed  Google Scholar 

  13. Picco L, Middleton M, Bruno R, Kowalski M, Nielsen S. Validation of the OWLS, a screening tool for measuring prescription opioid use disorder in primary care. Pain Med. 2020;21(11):2757–64. https://doi.org/10.1093/pm/pnaa275.

    Article  PubMed  Google Scholar 

  14. Lee C, Sharma M, Kantorovich S, Brenton A. A predictive algorithm to detect opioid use disorder: what is the utility in a primary care setting? Health Serv Res Manag Epidemiol. 2018;1(5):2333392817747467.

    Google Scholar 

  15. Chartash D, Paek H, Dziura JD, Ross BK, Nogee DP, Boccio E, et al. Identifying opioid use disorder in the emergency department: multi-system electronic health record–based computable phenotype derivation and validation study. JMIR Med Inform. 2019;7(4):e15794.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Afshar M, Sharma B, Bhalla S, Thompson HM, Dligach D, Boley RA, et al. External validation of an opioid misuse machine learning classifier in hospitalized adult patients. Addict Sci Clin Pract. 2021;16(1):19.

    Article  PubMed  PubMed Central  Google Scholar 

  17. World Drug Report 2021 [Internet]. United Nations : Office on Drugs and Crime. [cited 2021 Aug 31]. Available from: https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html.

  18. Palumbo SA, Adamson KM, Krishnamurthy S, Manoharan S, Beiler D, Seiwell A, et al. Assessment of probable opioid use disorder using electronic health record documentation. JAMA Netw Open. 2020;3(9):e2015909–e2015909.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cheatle MD, Compton PA, Dhingra L, Wasser TE, O’Brien CP. Development of the revised opioid risk tool to predict opioid use disorder in patients with chronic nonmalignant pain. J Pain. 2019;20(7):842–51.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Carrell DS, Albertson-Junkans L, Ramaprasan A, Scull G, Mackwood M, Johnson E, et al. Measuring problem prescription opioid use among patients receiving long-term opioid analgesic treatment: development and evaluation of an algorithm for use in EHR and claims data. J Drug Assess. 2020;9(1):97–105.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ni Y, Bachtel A, Nause K, Beal S. Automated detection of substance use information from electronic health records for a pediatric population. J Am Med Inform Assoc. 2021;28(10):2116–27. https://doi.org/10.1093/jamia/ocab116.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Annis IE, Jordan R, Thomas KC. Quickly identifying people at risk of opioid use disorder in emergency departments: trade-offs between a machine learning approach and a simple EHR flag strategy. BMJ Open. 2022;12(9):e059414. Published 2022 Sep 14. https://doi.org/10.1136/bmjopen-2021-059414.

  23. Prescription Drug Monitoring Programs (PDMPs) | CDC’s Response to the Opioid Overdose Epidemic | CDC [Internet]. 2021 [cited 2021 Aug 31]. Available from: https://www.cdc.gov/opioids/providers/pdmps.html.

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: Kimberley C. Brondeel, Kevin T. Malone, Frederick R. Ditmars, Bridget A. Vories, Shahab Ahmadzadeh, Sridhar Tirumala, Charles J. Fox, Sahar Shekoohi, Elyse M. Cornett, Alan D. Kaye. Analysis and interpretation of data: Kimberley C. Brondeel, Kevin T. Malone, Frederick R. Ditmars, Bridget A. Vories, Shahab Ahmadzadeh, Sridhar Tirumala, Charles J. Fox, Sahar Shekoohi, Elyse M. Cornett, Alan D. Kaye. Drafting of the manuscript: Kimberley C. Brondeel, Kevin T. Malone, Frederick R. Ditmars, Bridget A. Vories, Shahab Ahmadzadeh, Sridhar Tirumala, Charles J. Fox, Sahar Shekoohi, Elyse M. Cornett, Alan D. Kaye. Critical revision of the manuscript for important intellectual content: Kimberley C. Brondeel, Kevin T. Malone, Frederick R. Ditmars, Bridget A. Vories, Shahab Ahmadzadeh, Sridhar Tirumala, Charles J. Fox, Sahar Shekoohi, Elyse M. Cornett, Alan D. Kaye. Statistical analysis: Kimberley C. Brondeel, Kevin T. Malone, Frederick R. Ditmars, Bridget A. Vories, Shahab Ahmadzadeh, Sridhar Tirumala, Charles J. Fox, Sahar Shekoohi, Elyse M. Cornett, Alan D. Kaye.

Corresponding author

Correspondence to Sahar Shekoohi.

Ethics declarations

Conflict of Interest

Kimberley C. Brondeel has nothing to disclose. Kevin T. Malone has nothing to disclose. Frederick R. Ditmars has nothing to disclose. Bridget A. Vories has nothing to disclose. Shahab Ahmadzadeh has nothing to disclose. Sridhar Tirumala has nothing to disclose. Charles J. Fox has nothing to disclose. Sahar Shekoohi has nothing to disclose. Elyse M. Cornett has nothing to disclose. Alan D. Kaye has nothing to disclose.

Human and Animal Rights and Informed Consent

This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Acute Pain Medicine

Highlights

• A multi-algorithm approach using EHR yielded strong predictive values of OUD over a large sample size.

• A POR algorithm provided a high sensitivity for categorizing the risk of opioid abuse within a small sample size.

• All established screening methods and algorithms reflected high sensitivity and positive predictive values.

• Neural networks based on EHR also showed significant effectiveness when corroborated with Drug Abuse Manual Screenings.

• A manual screening approach leads to a high sensitivity; such methods as OWLS or Rapid Opioid Dependence Screen (RODS) are quick and sensitive and can be tailored to an individual’s practice.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brondeel, K.C., Malone, K.T., Ditmars, F.R. et al. Algorithms to Identify Nonmedical Opioid Use. Curr Pain Headache Rep 27, 81–88 (2023). https://doi.org/10.1007/s11916-023-01104-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-023-01104-7

Keywords

Navigation